Lenabasum an effective and safe treatment for amyopathic dermatomyositis Dr. Kamal Kant Kohli2 Nov 2022 2:30 AM ISTLenabasum is a cannabinoid receptor type 2 agonist that triggers the resolution of inflammation. Researchers have found in a new study that Lenabasum...
Is it time to revise standard cut off of 300 ng/dL for testosterone deficiency in young men? Medha Baranwal1 Nov 2022 7:30 PM ISTUSA: A recent study in the Journal of Urology has suggested that age-specific testosterone cutoffs and reference ranges should be used for evaluating...
Consumption of vitamin B6 and folate protects against CVD in type 2 diabetes patients Medha Baranwal1 Nov 2022 12:15 PM ISTChina: Greater consumption of vitamin B6 and folate, but not of vitamin B12, is associated with low cardiovascular disease (CVD) risk in type 2...
Coffee consumption may prolong prostate cancer-specific survival, study finds Medha Baranwal1 Nov 2022 11:15 AM ISTUSA: In a large study published in European Urology Oncology, coffee consumption in men with prostate cancer and fast caffeine metabolism are...
Combined oral contraceptives don't increase macromastia risk after breast reduction surgery among adolescents Dr. Kamal Kant Kohli1 Nov 2022 11:00 AM ISTUSA: Researchers have found in a new study that combined oral contraceptives (COCs) do not increase the risk of macromastia nor do they increase...
Single dose of antibody-drug prevents malaria infection in African adults Isra Zaman1 Nov 2022 9:45 AM ISTAn estimated 241 million cases of malaria occurred worldwide in 2020, according to the World Health Organization (WHO), resulting in an estimated...
Urine bicarbonate test offers new, safe quantification of CFTR function in cystic fibrosis patients Dr. Kamal Kant Kohli1 Nov 2022 9:30 AM ISTA study of 50 adult patients with cystic fibrosis (CF) has found that challenged urine bicarbonate excretion may offer a new, simple, and safe...
Ticagrelor-aspirin antiplatelet therapy more beneficial in persons with normal renal function Dr. Kamal Kant Kohli1 Nov 2022 2:45 AM ISTAn analysis of the CHANCE-2 trial has found that persons with normal renal function receive greater benefit from antiplatelet therapy with...
Apixaban associated with lower risk of GI bleeding compared to all DOACs Dr. Kamal Kant Kohli1 Nov 2022 2:45 AM ISTA multinational cohort study of persons with atrial fibrillation (AF) found that compared with all direct oral anticoagulants (DOACs), apixaban was...
Genetic predisposition for SLE may protect against severe COVID-19 infection Dr. Kamal Kant Kohli31 Oct 2022 8:00 PM ISTSome genetic variants may put people at risk of autoimmune diseases while conferring protection against the outcome of viral infection. David Morris...
Statins may reduce risk of lung cancer among patients of idiopathic pulmonary fibrosis Dr. Kamal Kant Kohli31 Oct 2022 12:00 PM ISTKOREA: According to research findings presented at the American College of Chest Physicians (CHEST) 2022 Annual Meeting, conducted on October 16–19 in...
Experimental monoclonal antibodies show promise against Epstein-Barr virus Dr. Kamal Kant Kohli31 Oct 2022 10:30 AM ISTResearchers have discovered a panel of investigational monoclonal antibodies (mAbs) targeting different sites of the Epstein-Barr virus (EBV) blocked...
